Abstract
High circulating levels of insulin-like growth factor (IGF-I) may elevate the risk of breast cancer in premenopausal women, possibly by increasing cell proliferation and reducing apoptosis. We conducted a nested case-control study among 35,105 Norwegian women who participated in a health screening survey, ages 40 to 42 years, and who were subsequently followed for a mean period of 4.3 years. During this period, 325 women were diagnosed with breast cancer; 647 women without breast cancer, matched on age and time of blood sampling, were selected as controls. Serum concentrations of IGF-I and its main binding protein (IGFBP-3) were measured with radioimmunoassay, and logistic regression analysis was used to adjust for relevant covariates. The mean age at blood collection was 41.1 years in both groups, and the mean age at diagnosis for the cases was 45.4 years (range, 40-51 years). The median IGF-I level did not differ between cases (205 ng/mL) and controls (202 ng/mL). When analyzed by categories of serum IGF-I, the relative risk for women in the highest versus the lowest quintile was 1.46 (95% confidence interval, 0.93-2.32; P(trend) = 0.15) after adjusting for serum IGFBP-3, age, and year of blood collection. The exclusion of ca...Continue Reading
References
Jan 1, 1989·Journal of Clinical Epidemiology·I StensvoldO P Foss
Oct 1, 1996·Physiological Reviews·C E Stewart, P Rotwein
Oct 23, 1997·Nature Medicine·S T NgC A Bondy
Feb 7, 1998·Science·J M ChanM Pollak
May 21, 1998·Lancet·J Holly
May 21, 1998·Lancet·S E HankinsonM Pollak
Jun 6, 1998·The Journal of Endocrinology·T D CheethamD B Dunger
Jan 29, 1999·Journal of the National Cancer Institute·H YuX Wu
Apr 15, 1999·Journal of the National Cancer Institute·J MaM J Stampfer
Oct 25, 2000·British Journal of Cancer·A G RenehanS T O'Dwyer
Apr 28, 2004·Lancet·Andrew G RenehanMatthias Egger
Mar 16, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Eva S SchernhammerSusan E Hankinson
Dec 29, 2005·International Journal of Cancer. Journal International Du Cancer·Dimitrios TrichopoulosAntonia Trichopoulou
May 27, 2006·Endocrine-related Cancer·Andrew G RenehanAnthony Howell
May 27, 2006·Endocrine-related Cancer·Eva S SchernhammerSusan E Hankinson
May 27, 2006·Endocrine-related Cancer·S RinaldiR Kaaks
Citations
Nov 6, 2009·Breast Cancer Research and Treatment·Dana E RollisonMartha L Slattery
Feb 12, 2010·Nutrition & Metabolism·Christopher J MoultonSharon M Donovan
Feb 22, 2012·PloS One·I-Hsin LinRuey-Hong Wong
Jun 6, 2012·PloS One·Octavio P LuzardoLuis D Boada
Nov 28, 2012·PloS One·Hongxin CaoJiajun Du
Mar 12, 2011·Fertility and Sterility·Angela F TrinconiEdmund C Baracat
May 1, 2012·Cancer·Nancy U LinJane C Weeks
Jul 9, 2009·International Journal of Cancer. Journal International Du Cancer·Mei-Hsuan WuChien-An Sun
Dec 18, 2013·SpringerPlus·Xiaowei Sherry YanAzadeh Stark
May 18, 2010·The Lancet Oncology·UNKNOWN Endogenous Hormones and Breast Cancer Collaborative GroupAndrew W Roddam
Mar 9, 2012·Breast Cancer : Basic and Clinical Research·Roshni RaoDavid Euhus
Feb 26, 2020·Cancers·Junki SakataHideki Nakayama
Aug 28, 2020·OncoTargets and Therapy·Yifei ZhuKunwei Shen
Feb 26, 2016·Cancer Prevention Research·Ji YongLiMarie E Wood
Mar 27, 2021·Frontiers in Oncology·Ann H RosendahlHelena Jernström